A new venture fund, founded in 2019, based in the East Coast, is focused on investing in digital health technologies, with a secondary focus on enterprise software. The firm will consider all digital health companies, but has a particular interest in novel applications. The fund will invest between $50,000-1M in companies with a pre-money valuation of $2-12M, with some money reserved for follow-on investments. The firm will invest only in companies based in the US.
The firm is willing to consider all types of digital health technologies but is primarily focused on software and technology enabled services. The fund is most interested in products/services that address unmet needs and offer novel solutions, as opposed to those that are improving on products that already exist. For solutions that appear incremental, The firm applies a higher standard in terms of market validation and evidence of a repeatable sales process.
The firm looks to invest in companies with a pre-money valuation of no greater than 12M.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Leave a Reply